Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Global mammalian cell fermentation technology industry 360º synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Type trends
2.1.4 Application trends
2.1.5 End-use trends
Chapter 3 Mammalian Cell Fermentation Technology Industry Insights
3.1 Industry landscape
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing demand for biologics
3.2.1.2 Increasing investment in research and development of novel recombinant proteins
3.2.1.3 Increasing focus on personalized medicine and precision medicine
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with the production of biologics using mammalian cell fermentation technology
3.2.2.2 Regulatory challenges
3.3 Growth potential analysis
3.3.1 By type
3.3.2 By application
3.3.3 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Technology landscape
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Company positioning matrix
4.5 Strategy dashboard, 2022
Chapter 5 Mammalian Cell Fermentation Technology Market, By Type, 2018 - 2032 (USD Million)
5.1 Key trends, by type
5.2 Chinese Hamster Ovary (CHO) cell fermentation
5.3 Human Embryonic Kidney (HEK) cell fermentation
5.4 Baby Hamster Kidney (BHK) cell fermentation
5.5 Murine myeloma cell fermentation
5.6 Other types
Chapter 6 Mammalian Cell Fermentation Technology Market, By Application, 2018 – 2032 (USD Million)
6.1 Key trends, by application
6.2 Monoclonal antibodies
6.3 Recombinant proteins
6.4 Vaccines
6.5 Hormones
6.6 Enzymes
6.7 Other applications
Chapter 7 Mammalian Cell Fermentation Technology Market, By End-use, 2018 – 2032 (USD Million)
7.1 Key trends, by end-use
7.2 Biopharmaceutical Companies
7.3 CMOs & CDMOs
7.4 Academic & Research Institutes
Chapter 8 Mammalian Cell Fermentation Technology Market, By Region, 2018 – 2032 (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Rest of MEA
Chapter 9 Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.2 Merck KGaA
9.3 Danaher Corporation
9.4 Lonza Group Ltd
9.5 F. Hoffmann-La Roche Ltd
9.6 Sartorius AG
9.7 AstraZeneca PLC
9.8 Bristol-Myers Squibb Company
9.9 Amgen Inc.
9.10 Gilead Sciences, Inc.
9.11 Moderna, Inc.
9.12 Regeneron Pharmaceuticals, Inc.
